PLASMA PROTEIN CONCENTRATES OF REDUCED THROMBOGENICITY AND THEIR USE IN CLINICAL REPLACEMENT THERAPY

摘要

Plasma concentrates of vitamin-K dependent clotting factors of reduced thrombogenic potential useful for clinical replacement therapy in deficiency diseases of these clotting factors are provided. Preferably, concentrates substantially devoid of zymogens extraneous to the deficient factor are employed.